BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 752848)

  • 1. [Value of lymphography in the staging of prostatic cancer].
    Proca E; Zamfir V
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1978; 27(6):467-74. PubMed ID: 752848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphatic metastasis in prostatic carcinoma. Diagnostic value of staging and transcutaneous needle biopsy].
    Rothenberger K; Hofstetter A; Pfeifer KJ; Voeth C; Pensel J
    Fortschr Med; 1980 Sep; 98(34):1279-82. PubMed ID: 7461533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer. Staging through laparoscopic lymphadenectomy.
    Newton M; Moore S; Gaehle KE
    AORN J; 1994 Apr; 59(4):823-33, 836; quiz 837-40. PubMed ID: 8210240
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis, staging, and surgical treatment of prostatic carcinoma.
    Catalona WJ; Avioli LV
    Arch Intern Med; 1987 Feb; 147(2):361-3. PubMed ID: 3813756
    [No Abstract]   [Full Text] [Related]  

  • 6. Radical external beam radiation therapy for prostate carcinoma.
    Garrett PG; Herman JG; Rawlings GA; Hawkins NV; Gospodarowicz MK; Keen CW; Rider WD
    J Can Assoc Radiol; 1984 Jun; 35(2):139-43. PubMed ID: 6480665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of clinical staging of prostatic cancer with regard to the degree of histopathological malignancy].
    Szymanowski J; Wasilewski A
    Pol Tyg Lek; 1982 Jul; 37(24-25):709-12. PubMed ID: 7177967
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of pedal lymphography for staging untreated prostatic carcinoma. Prospective evaluation of pedal lymphography for pretherapeutic staging of prostatic carcinoma (TNM-classification according to the 1974 UICC recommendation)].
    Helzel MV; Pfitzenmaier N
    Rofo; 1982 Oct; 137(4):417-21. PubMed ID: 6216178
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction.
    Simon J; Kuefer R; Bartsch G; Volkmer BG; Hautmann RE; Gottfried HW
    BJU Int; 2008 Aug; 102(4):459-62. PubMed ID: 18325061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
    Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
    Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostatic cancer. Reliability of clinical staging and the prognostic significance of age, clinical stage and tumor morphology].
    Mihatsch MJ; Rist M; Ohnacker H; Oberholzer M; Spichtin HP; Schmassmann A; Perret A; Torhorst J; Rutishauser G
    Z Urol Nephrol; 1983 May; 76(5):281-97. PubMed ID: 6880416
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphology of prostate carcinoma in biopsies and total prostatectomies. Relevance of biopsy findings].
    Kastendieck H
    Pathologe; 1980 Nov; 2(1):31-43. PubMed ID: 7465545
    [No Abstract]   [Full Text] [Related]  

  • 13. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR; Bostwick DG; Myers RP; Oesterling JE
    J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
    Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postoperative pathomorphologic classification of prostate cancer. Recommendations for the processing of total prostatectomies and relevance of the findings].
    Kastendieck H; Hüsselmann H
    Pathologe; 1982 Sep; 3(5):278-86. PubMed ID: 7145866
    [No Abstract]   [Full Text] [Related]  

  • 17. Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
    Forman JD; Lee WR; Roach M; Perez CA; Beyer DC; Blasko JC; Hussey DH; Paryani SB; Pollack A; Potters L; Scardino P; Schellhammer P; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1373-82. PubMed ID: 11037553
    [No Abstract]   [Full Text] [Related]  

  • 18. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy?
    Gingrich JR; Paulson DF
    Surg Oncol Clin N Am; 1995 Apr; 4(2):335-44. PubMed ID: 7540939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of M0 prostatic adenocarcinoma: how aggressive should one be?
    Olsson CA
    Prog Clin Biol Res; 1984; 153():455-67. PubMed ID: 6473408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.